uc002nfj.1_intron_34_0_chr19_17320519

CTGCAGAGAGTATCGCCTTCCGCAGGCTTTCGCTCCTGCGACAAAATGCTGTGAGTACCGGTGATCGTGGGGGCGGGACCTCTTTGGTGGGGCGGAGCCTGGTGCTGGGCAGGGCCTTGGGCGTGGCTTTGTTGCTGGGAAGGCTGGTGAGTGGGGTCTTGGTGGGCGGGGCCTTGGGTGGGCAGGACCTCCCATGCCGAGGATGGGACCGGGTAGTGGGTGTGGTCTCGGGTAGCAGGGCGGGGCCTCC
..............................................................................((((......))))...(((((....((.(((((((((........))))...))))).)).))))).........................................................................................................
..............................................................................79...........................................................................156............................................................................................

Size

Perfect hit

Total Norm

Perfect Norm

SRR015361(GSM380326)
Memory B cells (MM55). (B cell)

SRR037944(GSM510482)
293DcrTN_cand5. (cell line)

SRR033719(GSM497064)
6hr Activated B cell line (ABC158). (B cell)

SRR033727(GSM497072)
HIV-positive DL (HIV412). (B cell)

SRR033720(GSM497065)
EBV activated B cell line (EBV159). (B cell)

SRR033730(GSM497075)
Lymphoblastic (ALL411). (B cell)

SRR039616(GSM531979)
HBV(+) Distal Tissue Sample 1. (liver)

SRR189784

SRR039615(GSM531978)
Severe Chronic Hepatitis B Liver Tissue. (liver)

SRR326279(GSM769509)
cytoplasmic fraction was isolated using PARIS. (cell line)

SRR060984(GSM569188)
Human plasma cell [09-001]. (cell line)

SRR015364(GSM380329)
Plasma B cells (PC44). (B cell)

TAX577741(Rovira)
total RNA. (breast)

SRR033728(GSM497073)
MALT (MALT413). (B cell)

SRR029054(GSM402329)
MCF7_smallRNAseq. (cell line)

SRR033718(GSM497063)
Multiple Myeloma (U266). (B cell)

SRR015359(GSM380324)
Germinal Center B cell (GC136). (B cell)

SRR060983(GSM569187)
Human pre-germinal center B cell [09-001]. (cell line)

SRR330900(SRX091738)
tissue: skin psoriatic uninvolveddisease stat. (skin)

SRR107297(GSM677704)
18-30nt fraction of small RNA. (cell line)

GSM450607(GSM450607)
miRNA sequencing raw reads from post-mortem s. (brain)

SRR553572(SRX182778)
source: Frontal Cortex. (Frontal Cortex)

SRR039190(GSM494809)
PBMCs were isolated by ficoll gradient from t. (blood)

SRR189783

DRR000556(DRX000314)
"THP-1 whole cell RNA, after 3 day treatment . (cell line)

SRR330890(SRX091728)
tissue: skin psoriatic uninvolveddisease stat. (skin)

TAX577740(Rovira)
total RNA. (breast)

SRR015358(GSM380323)
Nàøve B Cell (Naive39). (B cell)

SRR033721(GSM497066)
Ly3 cell line (Ly3). (B cell)

SRR033725(GSM497070)
Unmutated CLL (CLLU626). (B cell)

SRR040008(GSM532893)
G727N. (cervix)

SRR033726(GSM497071)
Mututated CLL (CLLM633). (B cell)

SRR189786

SRR040024(GSM532909)
G613N. (cervix)

SRR039619(GSM531982)
HBV(+) HCC Tissue Sample 1. (liver)

SRR326280(GSM769510)
total cell content of unperturbed cells was s. (cell line)

SRR060981(GSM569185)
Human centroblast [09-001]. (cell line)

SRR039611(GSM531974)
Human Normal Liver Tissue Sample 1. (liver)

SRR038852(GSM458535)
QF1160MB. (cell line)

SRR553573(SRX182779)
source: Cerebellum. (Cerebellum)

SRR330898(SRX091736)
tissue: skin psoriatic uninvolveddisease stat. (skin)

...................................................................................TTGGTGGGGCGGAGCAAG.....................................................................................................................................................

23.00

0.00

4.00

2.00

3.00

2.00

1.00

...................................................................................TTGGTGGGGCGGAGCAAGA....................................................................................................................................................

12.00

0.00

1.00

2.00

1.00

...................................................................................TTGGTGGGGCGGAGCAA......................................................................................................................................................

3.00

0.00

1.00

....................................................................................................................................TGCTGGGAAGGCTGGTCTCG..................................................................................................

1.00

0.00

1.00

...................................................................................TTGGTGGGGCGGAGCGAG.....................................................................................................................................................

1.00

0.00

1.00

................................................................................................GCCTGGTGCTGGGCAGTTTT......................................................................................................................................

1.00

0.00

1.00

...................................................................................TTGGTGGGGCGGAGCAAA.....................................................................................................................................................

1.00

0.00

1.00

........................................................................................................................................GGGAAGGCTGGTGAGTGCT...............................................................................................

1.00

0.00

1.00

.....................................................................................GGTGGGGCGGAGCCTGGTGCTGGG.............................................................................................................................................

1.00

..............................................................................................................................................................TTGGTGGGCGGGGCCAGC..........................................................................

1.00

0.00

1.00

..................................................................................TTTGGTGGGGCGGAGCAAG.....................................................................................................................................................

1.00

0.00

1.00

..................................................GTGAGTACCGGTGATCGTGGGGGCGGGA............................................................................................................................................................................

1.00

...............................................GCTGTGAGTACCGGTGATCGTGGGGGC................................................................................................................................................................................

1.00

......................................CGACAAAATGCTGTGAGTACCGGTG...........................................................................................................................................................................................

1.00

................................................................TCGTGGGGGCGGGACG..........................................................................................................................................................................

1.00

0.00

1.00

................CTTCCGCAGGCTTTCACGA.......................................................................................................................................................................................................................

1.00

0.00

1.00

........................................................................................................................................GGGAAGGCTGGTGAGCGCG...............................................................................................

1.00

0.00

1.00

...................................................................................TTGGTGGGGCGGAGCA.......................................................................................................................................................

1.00

0.00

1.00

.................................................................................CTTTGGTGGGGCGGAGCAA......................................................................................................................................................

1.00

0.00

1.00

.......................................................................GGCGGGACCTCTTTGGAAGG...............................................................................................................................................................

1.00

0.00

1.00

..........................................................................................................................................................................................ACCTCCCATGCCGAG.................................................

0.50

CTGCAGAGAGTATCGCCTTCCGCAGGCTTTCGCTCCTGCGACAAAATGCTGTGAGTACCGGTGATCGTGGGGGCGGGACCTCTTTGGTGGGGCGGAGCCTGGTGCTGGGCAGGGCCTTGGGCGTGGCTTTGTTGCTGGGAAGGCTGGTGAGTGGGGTCTTGGTGGGCGGGGCCTTGGGTGGGCAGGACCTCCCATGCCGAGGATGGGACCGGGTAGTGGGTGTGGTCTCGGGTAGCAGGGCGGGGCCTCC ..............................................................................((((......))))...(((((....((.(((((((((........))))...))))).)).)))))......................................................................................................... ..............................................................................79...........................................................................156............................................................................................	Size	Perfect hit	Total Norm	Perfect Norm	SRR015361(GSM380326) Memory B cells (MM55). (B cell)	SRR037944(GSM510482) 293DcrTN_cand5. (cell line)	SRR033719(GSM497064) 6hr Activated B cell line (ABC158). (B cell)	SRR033727(GSM497072) HIV-positive DL (HIV412). (B cell)	SRR033720(GSM497065) EBV activated B cell line (EBV159). (B cell)	SRR033730(GSM497075) Lymphoblastic (ALL411). (B cell)	SRR039616(GSM531979) HBV(+) Distal Tissue Sample 1. (liver)	SRR189784	SRR039615(GSM531978) Severe Chronic Hepatitis B Liver Tissue. (liver)	SRR326279(GSM769509) cytoplasmic fraction was isolated using PARIS. (cell line)	SRR060984(GSM569188) Human plasma cell [09-001]. (cell line)	SRR015364(GSM380329) Plasma B cells (PC44). (B cell)	TAX577741(Rovira) total RNA. (breast)	SRR033728(GSM497073) MALT (MALT413). (B cell)	SRR029054(GSM402329) MCF7_smallRNAseq. (cell line)	SRR033718(GSM497063) Multiple Myeloma (U266). (B cell)	SRR015359(GSM380324) Germinal Center B cell (GC136). (B cell)	SRR060983(GSM569187) Human pre-germinal center B cell [09-001]. (cell line)	SRR330900(SRX091738) tissue: skin psoriatic uninvolveddisease stat. (skin)	SRR107297(GSM677704) 18-30nt fraction of small RNA. (cell line)	GSM450607(GSM450607) miRNA sequencing raw reads from post-mortem s. (brain)	SRR553572(SRX182778) source: Frontal Cortex. (Frontal Cortex)	SRR039190(GSM494809) PBMCs were isolated by ficoll gradient from t. (blood)	SRR189783	DRR000556(DRX000314) "THP-1 whole cell RNA, after 3 day treatment . (cell line)	SRR330890(SRX091728) tissue: skin psoriatic uninvolveddisease stat. (skin)	TAX577740(Rovira) total RNA. (breast)	SRR015358(GSM380323) Nàøve B Cell (Naive39). (B cell)	SRR033721(GSM497066) Ly3 cell line (Ly3). (B cell)	SRR033725(GSM497070) Unmutated CLL (CLLU626). (B cell)	SRR040008(GSM532893) G727N. (cervix)	SRR033726(GSM497071) Mututated CLL (CLLM633). (B cell)	SRR189786	SRR040024(GSM532909) G613N. (cervix)	SRR039619(GSM531982) HBV(+) HCC Tissue Sample 1. (liver)	SRR326280(GSM769510) total cell content of unperturbed cells was s. (cell line)	SRR060981(GSM569185) Human centroblast [09-001]. (cell line)	SRR039611(GSM531974) Human Normal Liver Tissue Sample 1. (liver)	SRR038852(GSM458535) QF1160MB. (cell line)	SRR553573(SRX182779) source: Cerebellum. (Cerebellum)	SRR330898(SRX091736) tissue: skin psoriatic uninvolveddisease stat. (skin)
..................TTGTCGCAGGAGCGAAAGCCTGCGGA..............................................................................................................................................................................................................	26	1	3.00	3.00	-	3.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
.........TCGCAGGAGCGAAAGCCTGCGGAAGGCGATAC.................................................................................................................................................................................................................	32	1	2.00	2.00	-	2.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
......................................................................................................................................CTGGGAAGGCTGGTGGAAT.................................................................................................	19		1.00	0.00	-	-	-	-	-	-	-	-	-	-	-	-	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
......................................................GTACCGGTGATCGTGGCA..................................................................................................................................................................................	18		1.00	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
..................................................................................................................................................................................................................................CTCGGGTAGCAGGGCTTGT.....	19		1.00	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00	-	-	-	-	-
................................................................................................CCTGCCCAGCACCAGGC.........................................................................................................................................	17	7	0.14	0.14	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.14